Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Lozanoc vs Sporanox in Healthy Korean Males
NCT02493738Phase 1Completed
- Sponsor
- Boryung
- Start
- Jul 2015
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of itraconazole in superficial mycoses, dermatomycosis, candidiasis and 1 more (2 arms), sponsored by Boryung. Primary endpoint: Maximum Plasma Concentration. Started Jul 2015; status: completed.
02
Drugs
itraconazole
03
Conditions
superficial mycosesdermatomycosiscandidiasishistoplasmosis
Beyond the preview
Go deeper on NCT02493738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493738.